Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan.

[1]  Emiko Masaki,et al.  Kazakhstan can achieve ambitious HIV targets despite expected donor withdrawal by combining improved ART procurement mechanisms with allocative and implementation efficiencies , 2017, PloS one.

[2]  Eli B. Silverman,et al.  Exploring How Substance Use Impedes Engagement along the HIV Care Continuum: A Qualitative Study , 2016, Front. Public Health.

[3]  Matt Anderson,et al.  European Monitoring Centre for Drugs and Drug Addiction , 2014 .

[4]  Maria A. Levi-Minzi,et al.  HIV stigma among substance abusing people living with HIV/AIDS: implications for HIV treatment. , 2014, AIDS patient care and STDs.

[5]  Bill J. Wright,et al.  The role of stigma in access to health care for the poor. , 2014, The Milbank quarterly.

[6]  N. El-Bassel,et al.  Access to HIV counseling and testing among people who inject drugs in Central Asia: strategies for improving access and linkages to treatment and care. , 2013, Drug and alcohol dependence.

[7]  S. Strathdee,et al.  HIV and people who use drugs in central Asia: confronting the perfect storm. , 2013, Drug and alcohol dependence.

[8]  W. El-Sadr,et al.  Antiretroviral therapy for prevention of HIV transmission: potential role for people who inject drugs in Central Asia. , 2013, Drug and alcohol dependence.

[9]  C. Beyrer,et al.  HIV Among Injection Drug Users and Their Intimate Partners in Almaty, Kazakhstan , 2013, AIDS and Behavior.

[10]  A. Howard,et al.  Evaluation of a Pilot Medication-Assisted Therapy Program in Kazakhstan: Successes, Challenges, and Opportunities for Scaleup , 2012, Advances in preventive medicine.

[11]  M Mofizul Islam,et al.  The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: a narrative synthesis of literature. , 2012, The International journal on drug policy.

[12]  R. Remien,et al.  Couple-Based HIV Prevention and Treatment: State of Science, Gaps, and Future Directions , 2012 .

[13]  Kathleen M. MacQueen,et al.  Applied Thematic Analysis , 2011 .

[14]  D. Shepard,et al.  Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward , 2010, The Lancet.

[15]  J. Montaner,et al.  Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis. , 2010, The Lancet. Infectious diseases.

[16]  S. Strathdee,et al.  Epidemiology of HIV Among Injecting and Non-injecting Drug Users: Current Trends and Implications for Interventions , 2010, Current HIV/AIDS reports.

[17]  Frank J. Snyder,et al.  The theory of triadic influence. , 2009 .

[18]  S. Strathdee,et al.  Adherence to Antiretroviral Therapy Among HIV-Infected Drug Users: A Meta-Analysis , 2010, AIDS and Behavior.

[19]  Matthew Hickman,et al.  Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review , 2008, The Lancet.

[20]  B. Yip,et al.  Highly active antiretroviral therapy and survival in HIV-infected injection drug users. , 2008, JAMA.

[21]  S. Strathdee,et al.  Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. , 2008, Addiction.

[22]  D. Wolfe.  Paradoxes in antiretroviral treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet Union. , 2007, The International journal on drug policy.

[23]  N. Bobrova,et al.  Obstacles in provision of anti-retroviral treatment to drug users in Central and Eastern Europe and Central Asia: a regional overview. , 2007, The International journal on drug policy.

[24]  R. Remien,et al.  Moving From Theory to Research to Practice: Implementing an Effective Dyadic Intervention to Improve Antiretroviral Adherence for Clinic Patients , 2006, Journal of acquired immune deficiency syndromes.

[25]  R. Hogg,et al.  Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. , 2006, Drug and alcohol dependence.

[26]  S. Shade,et al.  Individual, Interpersonal, and Structural Correlates of Effective HAART Use Among Urban Active Injection Drug Users , 2006, Journal of acquired immune deficiency syndromes.

[27]  A. Carballo-Diéguez,et al.  Couple-focused support to improve HIV medication adherence: a randomized controlled trial , 2005, AIDS.

[28]  R. Crosby,et al.  Emerging theories in health promotion practice and research , 2002 .

[29]  Kimberly A. Neuendorf,et al.  The Content Analysis Guidebook , 2001 .

[30]  Richard D Moore,et al.  Detrimental Effects of Continued Illicit Drug Use on the Treatment of HIV‐1 Infection , 2001, Journal of acquired immune deficiency syndromes.

[31]  K. Hawkins,et al.  Predictors of nonadherence to HIV-related medication regimens during methadone stabilization. , 2001, The American journal on addictions.

[32]  R. Chaisson,et al.  Race, sex, drug use, and progression of human immunodeficiency virus disease. , 1995, The New England journal of medicine.